Swedish Orphan Bio S/Adr (SWTUY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||
| Net Income | 134,732 | 94,581 | N/A |
| Depreciation Amortization | 57,005 | 51,519 | N/A |
| Income taxes - deferred | 20,490 | 18,325 | N/A |
| Accounts receivable | -43,388 | -72,334 | N/A |
| Accounts payable and accrued liabilities | 53,379 | 48,321 | N/A |
| Other Working Capital | -11,501 | -35,024 | N/A |
| Other Operating Activity | -54,364 | -65,309 | 0 |
| Operating Cash Flow | $156,354 | $40,080 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -10,641 | -4,589 | N/A |
| Purchase Of Investment | -87 | -12 | N/A |
| Purchase Sale Intangibles | -5,574 | -13,871 | N/A |
| Other Investing Activity | -5,574 | -13,871 | 0 |
| Investing Cash Flow | $-16,302 | $-18,471 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 58,089 | N/A |
| Debt Repayment | -58,650 | -96,793 | N/A |
| Common Stock Issued | N/A | 2,747 | N/A |
| Financing Cash Flow | $-58,650 | $-35,957 | $N/A |
| Exchange Rate Effect | -148 | 569 | N/A |
| Beginning Cash Position | 92,173 | 105,638 | N/A |
| End Cash Position | 173,428 | 91,859 | N/A |
| Net Cash Flow | $81,254 | $-13,779 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | 156,354 | 40,080 | N/A |
| Capital Expenditure | -10,783 | -5,355 | N/A |
| Free Cash Flow | 145,572 | 34,725 | 0 |